silybin has been researched along with meglumine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cao, X; Deng, WW; Fu, M; Su, WY; Tong, SS; Wang, L; Wei, YW; Xu, XM; Xu, Y; Yu, JN | 1 |
Barrajón-Catalán, E; Bonavia, R; Bosch-Barrera, J; Corominas-Faja, B; Cufí, S; Cuyàs, E; Joven, J; Martin-Castillo, B; Menendez, JA; Micol, V; Oliveras-Ferraros, C; Segura-Carretero, A; Vazquez-Martin, A; Visa, J | 1 |
Li, LC; Mao, S; Ni, R; Sun, W; Xu, D | 1 |
Chen, D; Feng, J; Gong, T; Guo, C; He, Q; Li, J; Song, X; Tan, T; Tan, Y; Yang, Q | 1 |
5 other study(ies) available for silybin and meglumine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.
Topics: Absorption; Analysis of Variance; Animals; Dogs; Drug Carriers; Gastric Juice; Hydrogen-Ion Concentration; Linear Models; Male; Meglumine; Models, Biological; Nanoparticles; Particle Size; Porosity; Silicon Dioxide; Silybin; Silymarin | 2012 |
Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Gefitinib; Humans; Meglumine; Mice; Mice, Inbred NOD; Plant Extracts; Protein Kinase Inhibitors; Quinazolines; Seeds; Silybin; Silybum marianum; Silymarin; Tandem Mass Spectrometry; Xenograft Model Antitumor Assays | 2013 |
In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
Topics: Animals; Animals, Inbred Strains; Antioxidants; Biological Availability; Dogs; Drug Compounding; Drug Liberation; Drug Stability; Excipients; Male; Meglumine; Microscopy, Electron, Scanning; Nanoparticles; Oral Mucosal Absorption; Particle Size; Powders; Rats, Wistar; Silybin; Silymarin; Suspensions; Tablets | 2015 |
Combined Amphiphilic Silybin Meglumine Nanosuspension Effective Against Hepatic Fibrosis in Mice Model.
Topics: Animals; Biological Availability; Collagen Type I; Disease Models, Animal; Liver Cirrhosis; Meglumine; Mice; Silybin | 2023 |